Pulmonary Fibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pulmonary Fibrosis stocks.

Pulmonary Fibrosis Stocks Recent News

Date Stock Title
May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
May 1 GLTO Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab
May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
May 1 MORF Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation
Apr 30 BIIB Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
Apr 30 BIIB Biogen: Don't Overthink This One
Apr 29 BIIB The Analyst Landscape: 27 Takes On Biogen
Apr 29 BIIB 10 Most Promising Stocks to Buy Before They Take Off
Apr 29 BIIB Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
Apr 29 FGEN FibroGen to Report First Quarter 2024 Financial Results
Apr 29 OCEA Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Apr 29 BIIB Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Apr 28 BIIB Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Apr 27 GYRE Public companies are Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) biggest owners and were rewarded after market cap rose by US$137m last week
Apr 27 BIIB Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 26 MORF Morphic Holding files automatic mixed shelf
Apr 26 BIIB Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Apr 26 BIIB The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.

Browse All Tags